Position in GRAL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$32,631,831
+$15,323,889 QoQ
Shares Held
477,982
+42.7% QoQ
Ownership
1.07%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 374 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026VANGUARD PORTFOLIO MANAGEMENT LLC holds $22,945,604,526 across 31 Diagnostics & Research names. GRAL ranks #21 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
6,226,169 | $3,121,552,089 | |
| 2 | DHR |
Danaher Corp /De/
|
14,205,213 | $2,705,808,972 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
3,896,521 | $2,051,284,515 | |
| 4 | A |
Agilent Technologies, Inc.
|
14,442,441 | $1,918,389,438 | |
| 5 | WAT |
Waters Corp /De/
|
4,740,524 | $1,777,886,120 | |
| 6 | NTRA |
Natera, Inc.
|
5,782,640 | $1,569,697,628 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
7,501,993 | $1,449,535,087 | |
| 8 | DGX |
Quest Diagnostics Inc
|
6,131,045 | $1,299,474,987 |
All Filings in GRAL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,631,831 | 477,982 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $17,307,942 | 334,906 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||